710 related articles for article (PubMed ID: 15535832)
41. Administration of anti-type II collagen antibody sustains footpad swelling of mice caused by a delayed-type hypersensitivity reaction and induces severe arthritis.
Tanaka D; Kagari T; Doi H; Shimozato T
Clin Exp Immunol; 2007 May; 148(2):360-7. PubMed ID: 17335554
[TBL] [Abstract][Full Text] [Related]
42. T cell regulation of collagen-induced arthritis in mice. II. Immunomodulation of arthritis by cytotoxic T cell hybridomas specific for type II collagen.
Chiocchia G; Boissier MC; Manoury B; Fournier C
Eur J Immunol; 1993 Feb; 23(2):327-32. PubMed ID: 8436167
[TBL] [Abstract][Full Text] [Related]
43. Identification of an immunodominant type-II collagen peptide recognized by T cells in H-2q mice: self tolerance at the level of determinant selection.
Michaëlsson E; Andersson M; Engström A; Holmdahl R
Eur J Immunol; 1992 Jul; 22(7):1819-25. PubMed ID: 1378019
[TBL] [Abstract][Full Text] [Related]
44. A novel recombinant peptide containing only two T-cell tolerance epitopes of chicken type II collagen that suppresses collagen-induced arthritis.
Xi C; Tan L; Sun Y; Liang F; Liu N; Xue H; Luo Y; Yuan F; Sun Y; Xi Y
Mol Immunol; 2009 Feb; 46(4):729-37. PubMed ID: 19041137
[TBL] [Abstract][Full Text] [Related]
45. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
[TBL] [Abstract][Full Text] [Related]
46. Mice producing less reactive oxygen species are relatively resistant to collagen glycopeptide vaccination against arthritis.
Batsalova T; Dzhambazov B; Klaczkowska D; Holmdahl R
J Immunol; 2010 Sep; 185(5):2701-9. PubMed ID: 20686129
[TBL] [Abstract][Full Text] [Related]
47. Analysis of type II collagen-reactive T cells in the mouse. I. Different regulation of autoreactive vs. non-autoreactive anti-type II collagen T cells in the DBA/1 mouse.
Andersson M; Holmdahl R
Eur J Immunol; 1990 May; 20(5):1061-6. PubMed ID: 1694131
[TBL] [Abstract][Full Text] [Related]
48. Epitope specificity and T cell receptor usage in type II collagen induced autoimmune ear disease.
Yoo TJ; Lee MK; Min YS; Chiang HJ; Wang K; Fujiyoshi T; Watanabe T; Krug MS; Seyer J; Cheng KC
Cell Immunol; 1994 Aug; 157(1):249-62. PubMed ID: 7518752
[TBL] [Abstract][Full Text] [Related]
49. The mouse model of collagen-induced arthritis.
Brand DD; Kang AH; Rosloniec EF
Methods Mol Med; 2004; 102():295-312. PubMed ID: 15286392
[TBL] [Abstract][Full Text] [Related]
50. Reduction of the incidence and severity of collagen-induced arthritis by constitutive Nur77 expression in the T cell lineage.
De Silva S; Han S; Zhang X; Huston DP; Winoto A; Zheng B
Arthritis Rheum; 2005 Jan; 52(1):333-8. PubMed ID: 15641076
[TBL] [Abstract][Full Text] [Related]
51. The B cell response to autologous type II collagen: biased V gene repertoire with V gene sharing and epitope shift.
Mo JA; Holmdahl R
J Immunol; 1996 Sep; 157(6):2440-8. PubMed ID: 8805643
[TBL] [Abstract][Full Text] [Related]
52. Modulation of established murine collagen-induced arthritis by a single inoculation of short-term lipopolysaccharide-stimulated dendritic cells.
Salazar L; Aravena O; Abello P; Escobar A; Contreras-Levicoy J; Rojas-Colonelli N; Catalán D; Aguirre A; Zúñiga R; Pesce B; González C; Cepeda R; Cuchacovich M; Molina MC; Salazar-Onfray F; Delgado M; Toes RE; Aguillón JC
Ann Rheum Dis; 2008 Sep; 67(9):1235-41. PubMed ID: 18056756
[TBL] [Abstract][Full Text] [Related]
53. Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background.
Zhou F; He X; Iwakura Y; Horai R; Stuart JM
Arthritis Rheum; 2005 Dec; 52(12):3731-8. PubMed ID: 16320323
[TBL] [Abstract][Full Text] [Related]
54. Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice.
Myers LK; Sakurai Y; Tang B; He X; Rosloniec EF; Stuart JM; Kang AH
Arthritis Rheum; 2002 Dec; 46(12):3369-77. PubMed ID: 12483744
[TBL] [Abstract][Full Text] [Related]
55. Vaccination with an immunodominant peptide of bovine type II collagen induces an anti-TCR response, and modulates the onset and severity of collagen-induced arthritis.
Honda A; Ametani A; Matsumoto T; Iwaya A; Kano H; Hachimura S; Ohkawa K; Kaminogawa S; Suzuki K; Sercarz EE; Kumar V
Int Immunol; 2004 May; 16(5):737-45. PubMed ID: 15096482
[TBL] [Abstract][Full Text] [Related]
56. IL-15 exacerbates collagen-induced arthritis with an enhanced CD4+ T cell response to produce IL-17.
Yoshihara K; Yamada H; Hori A; Yajima T; Kubo C; Yoshikai Y
Eur J Immunol; 2007 Oct; 37(10):2744-52. PubMed ID: 17823984
[TBL] [Abstract][Full Text] [Related]
57. A synthetic peptide analogue of a determinant of type II collagen prevents the onset of collagen-induced arthritis.
Myers LK; Rosloniec EF; Seyer JM; Stuart JM; Kang AH
J Immunol; 1993 May; 150(10):4652-8. PubMed ID: 8482852
[TBL] [Abstract][Full Text] [Related]
58. Antigen processing and presentation of a naturally glycosylated protein elicits major histocompatibility complex class II-restricted, carbohydrate-specific T cells.
Michaëlsson E; Broddefalk J; Engström A; Kihlberg J; Holmdahl R
Eur J Immunol; 1996 Aug; 26(8):1906-10. PubMed ID: 8765038
[TBL] [Abstract][Full Text] [Related]
59. Genetic control of tolerance to type II collagen and development of arthritis in an autologous collagen-induced arthritis model.
Bäcklund J; Nandakumar KS; Bockermann R; Mori L; Holmdahl R
J Immunol; 2003 Oct; 171(7):3493-9. PubMed ID: 14500645
[TBL] [Abstract][Full Text] [Related]
60. Murine T cells reactive to type II collagen. II. Functional characterization.
Hom JT; Stuart JM; Tovey J; Chiller JM
J Immunol; 1986 Feb; 136(3):776-82. PubMed ID: 2416831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
